postsynaptic dorsal column spinal cord stimulation

Postsynaptic dorsal column spinal cord stimulation software#

Y aunque pareciera útil su aplicación en el dolor de tipo fantasma y en aquel asociado a enfermedad vascular periférica o cardiovascular, no existe una evidencia sólida para generalizar su empleo. El síndrome de cirugía espinal fallida muestra las mejores tasas de respuesta, aunque en casos de síndrome doloroso regional complejo y neuropatía diabética, así como de radiculopatía y lumbago sin cirugía espinal previa también se logra una reducción importante de dolor. La EME ha mostrado beneficio sobretodo en dolor de tipo neuropático. Estas se distinguen por la presencia de parestesias. DesarrolloĮn la actualidad existen diversos paradigmas de EME: tónica, de alta frecuencia en ráfaga o simplemente de alta frecuencia. El presente artículo describe las indicaciones para el tratamiento del dolor y otros usos no relacionados con este.

La descripción de la teoría de la compuerta del dolor fue el punto de partida para el desarrollo de la estimulación de la médula espinal (EME). Indications for SCS could include other diseases, and its use could be expanded, if the costs of the technology are reduced.

Postsynaptic dorsal column spinal cord stimulation software#

The perfection of hardware and software may improve its effectiveness and reduce the rate of complications. In its 50-year history, SCS has progressed enormously. The main limiting factors for the use of SCS are mechanical complications and the cost of the treatment. Non-pain-related indications for SCS are movement disorders, spasticity, and sequelae of spinal cord injury. SCS also improves cancer-related pain, although research on this issue is scarce. Phantom pain or pain related to cardiovascular or peripheral vascular disease may improve, although there is a lack of robust evidence supporting generalisation of its use. Patients with failed back surgery syndrome show the best response rates, although a considerable reduction in pain is also observed in patients with complex regional pain syndrome, diabetic neuropathy, radiculopathy, and low back pain without previous surgery. SCS is most beneficial for treating neuropathic pain. The main difference lies in the presence of paraesthesias. There are currently several paradigms for SCS: tonic, burst, and high frequency. We describe the indications for the treatment in pain management and other uses not related to pain. The gate control theory of pain was the starting point of the development of spinal cord stimulation (SCS).